Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of innovative, small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate, CT1812, is an o... Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of innovative, small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate, CT1812, is an orally delivered, small molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.02 | 4.87804878049 | 0.41 | 0.55 | 0.38 | 482524 | 0.41919966 | CS |
| 4 | -0.1442 | -25.1132009753 | 0.5742 | 0.65 | 0.36 | 2875898 | 0.49491517 | CS |
| 12 | -0.72 | -62.6086956522 | 1.15 | 1.29 | 0.36 | 8199893 | 0.5973584 | CS |
| 26 | -0.174 | -28.8079470199 | 0.604 | 1.29 | 0.34 | 4406417 | 0.56837809 | CS |
| 52 | -1.52 | -77.9487179487 | 1.95 | 3.44 | 0.34 | 2468152 | 0.66153992 | CS |
| 156 | -2.23 | -83.8345864662 | 2.66 | 6.2686 | 0.34 | 935848 | 0.89511205 | CS |
| 260 | -11.72 | -96.4609053498 | 12.15 | 13.8 | 0.34 | 831849 | 1.01088288 | CS |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
